Interpreting Null Gene-Expression Findings in the Selank IMR-32 Cell Study: Evidence and Limitations
A detailed analysis of the 2017 Selank study in IMR-32 neuroblastoma cells, focusing on the interpretation of its null gene-expression results, the experimental context, and the implications for peptide research.
2026-10-08Read resource
